CFDE Data Portal | Search XRCC4

	Label	Description
	XRCC4 associations Collection (Entity type)	Associations for XRCC4_associations
	XRCC4 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE159678 4 V 2 CHLOROQUINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 6 V 5 CRIZOTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	XRCC4 Gene (Entity type)	ENSG00000152422 - X-ray repair cross complementing 4
	GSE169152 3 V 6 IBRUTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135352 6 V 4 NAPABUCASIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE214596,GSE214598 1 V 0 ROSIGLITAZONE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE168797 4 V 6 CANNABIDIOL HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE232944 APC CTNNB1 overexpression HT29 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

XRCC4 associations

Associations for XRCC4_associations

XRCC4 associations.tsv

A file from IDG as part of the Harmonizome project

GSE159678 4 V 2 CHLOROQUINE HUMAN UP

A Gene Set from LINCS

GSE239844 6 V 5 CRIZOTINIB HUMAN DN

A Gene Set from LINCS

XRCC4

ENSG00000152422 - X-ray repair cross complementing 4

GSE169152 3 V 6 IBRUTINIB HUMAN DN

A Gene Set from LINCS

GSE135352 6 V 4 NAPABUCASIN HUMAN UP

A Gene Set from LINCS

GSE214596,GSE214598 1 V 0 ROSIGLITAZONE MOUSE UP

A Gene Set from LINCS

GSE168797 4 V 6 CANNABIDIOL HUMAN DN

A Gene Set from LINCS

GSE232944 APC CTNNB1 overexpression HT29 1 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.